OR WAIT null SECS
A tidal wave of questions floats the need for more upstream automation.
The milestone approval of a gene-edited therapeutic paves the way for gene-editing technologies.
Both adherent and suspension cell culture approaches have their pros and cons, which must be considered for process development.
April 12, 2023
Lives are saved when time from vein to vein decreases.
April 02, 2023
The innovation of going from stainless-steel bioreactors to fixed-bed bioreactors shows an evolution in upstream optimization.
March 02, 2023
Process and plasmid design optimization, disposable equipment, and flexible platform processes all play important roles.
Decreasing vein to vein time saves lives.
November 02, 2022
Experts reveal how to identify the “right” biochemical, the process of sourcing biochemicals, sourcing challenges, and what industry professionals should know about the space.
October 12, 2022
Using a predictive modeling approach can help tighten up operator control over bioprocessing, which in turn can increase bioreactor output.
October 10, 2022
Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.
October 07, 2022
Thermo Fisher’s new centrifuge technology is designed to enable efficient, sustainable cell culture harvesting.
October 02, 2022
The industry revisits the pros and cons of microbial fermentation at scale for biotherapeutics.
September 02, 2022
A predictive modeling approach can offer tighter process control, which can optimize bioreactor output.